NEW YORK (Reuters Health) – The single-tablet combination of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) is effective for long-term viral suppression in previously untreated patients with HIV-1 infection, according to 96-week results from the AMBER trial. Week 48 primary analyses of the AMBER trial and the companion EMERALD trial showed that D/C/F/TAF had high, noninferior antiviral efficacy with...
Tag: <span>AIDS virus</span>
Post
Scientists discover first new HIV strain in nearly two decades
NOVEMBER 7, 2019, BY CNNWIRE For the first time in 19 years, a team of scientists has detected a new strain of HIV. The strain is a part of the Group M version of HIV-1, the same family of virus subtypes to blame for the global HIV pandemic, according to Abbott Laboratories, which conducted the...
Post
Less than 40 percent of all U.S. adults have ever had HIV testing
Marc A. Pitasi, M.P.H., from the U.S. Centers for Disease Control and Prevention, in Atlanta, and colleagues analyzed data from the Behavioral Risk Factor Surveillance System to determine the percentage of adults tested for HIV in the United States nationwide, including 50 local jurisdictions where the majority of new diagnoses of HIV infection were concentrated in 2016 and 2017 and seven...
Post
A new method for removing cells infected with the AIDS virus
The compound L-HIPPO is being used by researchers from Kumamoto University in Japan to eradicate HIV in viral reservoir cells. With the successful suppression of the AIDS virus (HIV) through medication, the focus turns toward its eradication. Researchers from Kumamoto University in Japan have developed a new compound that is key to the destruction...